|
Gulf
Pharmaceutical Industries
(Julphar)
was established in the year 1980 under the
able guidance of H.H. Sheikh Saqar Bin
Mohammed Al Qasimi, the Ruler of Ras Al
Khaimah. His Highness etched his everlasting
legacy when he envisioned a pharmaceutical
company that will make UAE self sufficient
in all of its therapeutic needs, providing
quality medicine at affordable prices. Since
its inception, Julphar has grown into a
world class, state of the art pharmaceutical
manufacturing company of the Arab World.
Julphar
has the distinction of being the first
pharmaceutical company in the UAE and one of
the largest in the entire Middle East
region. Since its first commercial
production in 1984, Julphar has become a
true multinational organization, traveling
great distances. With its production plants
located in UAE and Germany and its products
being marketed across the globe in over 40
countries and 5 continents, Julphar has
truly become a representative of UAE's
entrepreneurial capabilities.
Julphar
has more than 800 formulations and 184
brands under its flag with products in every
major Therapeutic category. Julphar's
product range includes Analgesics,
Anti-Malarial, Anti-Biotic, Anti-Amoebic,
Anthelmintics, Antihistamines, Vitamins &
Steroids. The company's product range can be
divided into the following major categories
* Local Anesthetics
* Cardiovascular Systems
* Endocrinology
* Central Nervous System
* Anti Infective
* Respiratory System
* Immunosuppressant
* Musculoskeletal & Joint
diseases
* Nutrition and Blood
* Oral Cavity &
Gastrointestinal Tract
* Skin And Para Medical
Products |
|
|
With presence in
almost all the generic categories,
Julphar
is indeed a one-stop solution to many of the
regions' pharmaceutical needs.
State of the Art Manufacturing Facilities
Our strength
Julphar's
commitment to quality has resulted in its
state of the art manufacturing facilities
and procedures. Our continuous endeavor can
be reflected in our achievement of
ISO 9001
and ISO
14001
certification.
Gulf Pharmaceutical
Industry's manufacturing facilities
for bulk drugs and dosage forms comply with
the stringent requirements of Good
Manufacturing Practices
(GMP)
and Good Laboratory Practices
(GLP),
and are approved by international health and
regulatory agencies like the
US FDA
and
European GMP..
These practices and approvals ensure that an
effective framework is always in place, not
only for manufacturing of high-quality
products, but also for the effective use of
resources and reduction of wastes.
As a
cosequence
Julphar
has been named
as
contract manufacturer by several US
companies;
Julphar
started
exporting to US in 2005.
Julphar
has 7 state of
the art Drug Manufacturing
facilities, each adhering to the
highest standards
of Production & Manufacturing
practices.
 |
